Keywords
Last Name

Paul C. Schroy III, MD, MPH

TitleProfessor
InstitutionBoston University School of Medicine
DepartmentMedicine
DivisionGastroenterology
Address85 E. Concord St
Boston MA 02118
Phone(617) 638-8335
ORCID ORCID Icon0000-0001-9273-7832
Other Positions
TitleProfessor
InstitutionBoston University School of Public Health
DepartmentEpidemiology

TitleActive Staff Privileges
InstitutionBoston Medical Center
DepartmentMedicine

 Research Expertise & Professional Interests
Utilizing an integrated approach that incorporates a strong background in clinical research, clinical experience and public health training, Dr. Schroy's research activities focus primarily on the development, implementation and evaluation of model programs for community-based colorectal cancer control. Current ongoing studies include: (1) exploring the role of shared decision-making as a strategy for increasing patient participation in colorectal cancer screening; (2) developing a risk assessment tool for predicting the presence of advanced neoplasia at screening colonoscopy; (3) evaluating the feasibility and validity of novel colorectal cancer screening strategies such as stool-based DNA testing and virtual colonoscopy; and (4) implementation of quality measures related to colorectal cancer screening.

 Self-Described Keywords
  • Colorectal cancer screening
  • Shared decision making
 Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Seibert RG, Hanchate AD, Berz JP, Schroy PC. National Disparities in Colorectal Cancer Screening Among Obese Adults. Am J Prev Med. 2017 Feb 21. PMID: 28236517.
    View in: PubMed
  2. Rohan EA, Slotman B, DeGroff A, Morrissey KG, Murillo J, Schroy P. Refining the Patient Navigation Role in a Colorectal Cancer Screening Program: Results From an Intervention Study. J Natl Compr Canc Netw. 2016 Nov; 14(11):1371-1378. PMID: 27799508.
    View in: PubMed
  3. Lowery JT, Ahnen DJ, Schroy PC, Hampel H, Baxter N, Boland CR, Burt RW, Butterly L, Doerr M, Doroshenk M, Feero WG, Henrikson N, Ladabaum U, Lieberman D, McFarland EG, Peterson SK, Raymond M, Samadder NJ, Syngal S, Weber TK, Zauber AG, Smith R. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review. Cancer. 2016 Sep 01; 122(17):2633-45. PMID: 27258162.
    View in: PubMed
  4. Ahnen DJ, Schroy PC, Weber TK. Regarding "Colorectal Cancer Screening Quality Measures: Beyond Colonoscopy". Clin Gastroenterol Hepatol. 2016 Nov; 14(11):1668-1669. PMID: 27266981.
    View in: PubMed
  5. Schroy PC, Duhovic E, Chen CA, Heeren TC, Lopez W, Apodaca DL, Wong JB. Risk Stratification and Shared Decision Making for Colorectal Cancer Screening: A Randomized Controlled Trial. Med Decis Making. 2016 May; 36(4):526-35. PMID: 26785715.
    View in: PubMed
  6. Calderwood AH, Schroy PC, Kluge MA, Cabral HJ, Burgess JF. Predictors of Adherence to Post-Polypectomy Surveillance Colonoscopy. J Health Care Poor Underserved. 2016; 27(1):261-279. PMID: 27763469.
    View in: PubMed
  7. Berger BM, Schroy PC, Dinh TA. Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness. Clin Colorectal Cancer. 2016 Sep; 15(3):e65-74. PMID: 26792032.
    View in: PubMed
  8. Calderwood AH, Thompson KD, Schroy PC, Lieberman DA, Jacobson BC. Response. Gastrointest Endosc. 2015 Sep; 82(3):583-4. PMID: 26279354.
    View in: PubMed
  9. Schroy PC, Wong JB, O'Brien MJ, Chen CA, Griffith JL. A Risk Prediction Index for Advanced Colorectal Neoplasia at Screening Colonoscopy. Am J Gastroenterol. 2015 Jul; 110(7):1062-71. PMID: 26010311.
    View in: PubMed
  10. Calderwood AH, Thompson KD, Schroy PC, Lieberman DA, Jacobson BC. Good is better than excellent: bowel preparation quality and adenoma detection rates. Gastrointest Endosc. 2015 Mar; 81(3):691-699.e1. PMID: 25708756.
    View in: PubMed
  11. Calderwood AH, Logan JR, Zurfluh M, Lieberman DA, Jacobson BC, Heeren TC, Schroy PC. Validity of a Web-based educational program to disseminate a standardized bowel preparation rating scale. J Clin Gastroenterol. 2014 Nov-Dec; 48(10):856-61. PMID: 24463841.
    View in: PubMed
  12. Qazi TM, O'Brien MJ, Farraye FA, Gould RW, Chen CA, Schroy PC. Epidemiology of goblet cell and microvesicular hyperplastic polyps. Am J Gastroenterol. 2014 Dec; 109(12):1922-32. PMID: 25350766.
    View in: PubMed
  13. Kwah J, Schroy PC, Jacobson BC, Calderwood AH. Erratum to: Whites and Blacks Have Similar Risk of Metachronous Advanced Colorectal Neoplasia. Dig Dis Sci. 2014 Oct; 59(10):2604. PMID: 24908136.
    View in: PubMed
  14. Kwah J, Schroy PC, Jacobson BC, Calderwood AH. Whites and blacks have similar risk of metachronous advanced colorectal neoplasia. Dig Dis Sci. 2014 Sep; 59(9):2264-71. PMID: 24700155.
    View in: PubMed
  15. Calderwood AH, Schroy PC, Lieberman DA, Logan JR, Zurfluh M, Jacobson BC. Boston Bowel Preparation Scale scores provide a standardized definition of adequate for describing bowel cleanliness. Gastrointest Endosc. 2014 Aug; 80(2):269-76. PMID: 24629422.
    View in: PubMed
  16. Schroy PC, Caron SE, Sherman BJ, Heeren TC, Battaglia TA. Risk assessment and clinical decision making for colorectal cancer screening. Health Expect. 2015 Oct; 18(5):1327-38. PMID: 23905546.
    View in: PubMed
  17. Schroy PC, Coe A, Chen CA, O'Brien MJ, Heeren TC. Prevalence of advanced colorectal neoplasia in white and black patients undergoing screening colonoscopy in a safety-net hospital. Ann Intern Med. 2013 Jul 2; 159(1):13-20. PMID: 23817700.
    View in: PubMed
  18. Schroy PC, Emmons KM, Peters E, Glick JT, Robinson PA, Lydotes MA, Mylvaganam SR, Coe AM, Chen CA, Chaisson CE, Pignone MP, Prout MN, Davidson PK, Heeren TC. Aid-assisted decision making and colorectal cancer screening: a randomized controlled trial. Am J Prev Med. 2012 Dec; 43(6):573-83. PMID: 23159252.
    View in: PubMed
  19. Schroy PC, Coe AM, Mylvaganam SR, Ahn LB, Lydotes MA, Robinson PA, Davis JT, Chen CA, Ashba J, Atkinson ML, Colditz GA, Heeren TC. The Your Disease Risk Index for colorectal cancer is an inaccurate risk stratification tool for advanced colorectal neoplasia at screening colonoscopy. Cancer Prev Res (Phila). 2012 Aug; 5(8):1044-52. PMID: 22689913.
    View in: PubMed
  20. Calderwood AH, Wasan SK, Heeren T, Schroy PC. 2012;4: 307-38. Patient and provider preferences for CRC screening: How does CT colonography compare to other modalities?. Int J Cancer Res Prev. 2012; 4:307-38..
  21. Mitchell S, Heyden R, Heyden N, Schroy P, Andrew S, Sadikova E, Wiecha J. A pilot study of motivational interviewing training in a virtual world. J Med Internet Res. 2011; 13(3):e77. PMID: 21946183.
    View in: PubMed
  22. Schroy PC, Mylvaganam S, Davidson P. Provider perspectives on the utility of a colorectal cancer screening decision aid for facilitating shared decision making. Health Expect. 2014 Feb; 17(1):27-35. PMID: 21902773.
    View in: PubMed
  23. Calderwood AH, Schroy PC. Colorectal cancer: Increasing colorectal cancer screening--miles to go. Nat Rev Gastroenterol Hepatol. 2011 Aug; 8(8):421-2. PMID: 21750514.
    View in: PubMed
  24. Levitzky BE, Brown CC, Heeren TC, Schroy PC. Performance of a risk index for advanced proximal colorectal neoplasia among a racially/ethnically diverse patient population (risk index for advanced proximal neoplasia). Am J Gastroenterol. 2011 Jun; 106(6):1099-106. PMID: 21326221.
    View in: PubMed
  25. Calderwood AH, Wasan SK, Heeren TC, Schroy PC. Patient and Provider Preferences for Colorectal Cancer Screening: How Does CT Colonography Compare to Other Modalities? Int J Canc Prev. 2011; 4(4):307-338. PMID: 25237287.
    View in: PubMed
  26. Boehmer U, Harris J, Bowen DJ, Schroy PC. Surveillance after colorectal cancer diagnosis in a safety net hospital. J Health Care Poor Underserved. 2010 Nov; 21(4):1138-51. PMID: 21099067.
    View in: PubMed
  27. Fletcher RH, Nadel MR, Allen JI, Dominitz JA, Faigel DO, Johnson DA, Lane DS, Lieberman D, Pope JB, Potter MB, Robin DP, Schroy PC, Smith RA. The quality of colonoscopy services--responsibilities of referring clinicians: a consensus statement of the Quality Assurance Task Group, National Colorectal Cancer Roundtable. J Gen Intern Med. 2010 Nov; 25(11):1230-4. PMID: 20703953.
    View in: PubMed
  28. Schroy PC, Emmons K, Peters E, Glick JT, Robinson PA, Lydotes MA, Mylvanaman S, Evans S, Chaisson C, Pignone M, Prout M, Davidson P, Heeren TC. The impact of a novel computer-based decision aid on shared decision making for colorectal cancer screening: a randomized trial. Med Decis Making. 2011 Jan-Feb; 31(1):93-107. PMID: 20484090.
    View in: PubMed
  29. Schroy PC, Glick JT, Robinson P, Lydotes MA, Heeren TC, Prout M, Davidson P, Wong JB. A cost-effectiveness analysis of subject recruitment strategies in the HIPAA era: results from a colorectal cancer screening adherence trial. Clin Trials. 2009 Dec; 6(6):597-609. PMID: 19933718.
    View in: PubMed
  30. Wasan SK, Schroy PC. Water-assisted unsedated colonoscopy: does the end justify the means? Gastrointest Endosc. 2009 Mar; 69(3 Pt 1):551-3. PMID: 19231498.
    View in: PubMed
  31. Itzkowitz S, Brand R, Jandorf L, Durkee K, Millholland J, Rabeneck L, Schroy PC, Sontag S, Johnson D, Markowitz S, Paszat L, Berger BM. A simplified, noninvasive stool DNA test for colorectal cancer detection. Am J Gastroenterol. 2008 Nov; 103(11):2862-70. PMID: 18759824.
    View in: PubMed
  32. Schroy PC, Glick JT, Wilson S, Robinson PA, Heeren TC. An effective educational strategy for improving knowledge, risk perception, and risk communication among colorectal adenoma patients. J Clin Gastroenterol. 2008 Jul; 42(6):708-14. PMID: 18574393.
    View in: PubMed
  33. Holt CL, Schroy PC. A new paradigm for increasing use of open-access screening colonoscopy. Clin Gastroenterol Hepatol. 2008 Apr; 6(4):377-8. PMID: 18387496.
    View in: PubMed
  34. Schroy PC, Glick JT, Robinson PA, Lydotes MA, Evans SR, Emmons KM. Has the surge in media attention increased public awareness about colorectal cancer and screening? J Community Health. 2008 Feb; 33(1):1-9. PMID: 18080203.
    View in: PubMed
  35. Noe M, Schroy P, Demierre MF, Babayan R, Geller AC. Increased cancer risk for individuals with a family history of prostate cancer, colorectal cancer, and melanoma and their associated screening recommendations and practices. Cancer Causes Control. 2008 Feb; 19(1):1-12. PMID: 17906935.
    View in: PubMed
  36. Schroy PC, Lal S, Glick JT, Robinson PA, Zamor P, Heeren TC. Patient preferences for colorectal cancer screening: how does stool DNA testing fare? Am J Manag Care. 2007 Jul; 13(7):393-400. PMID: 17620034.
    View in: PubMed
  37. Lieberman D, Nadel M, Smith RA, Atkin W, Duggirala SB, Fletcher R, Glick SN, Johnson CD, Levin TR, Pope JB, Potter MB, Ransohoff D, Rex D, Schoen R, Schroy P, Winawer S. Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. Gastrointest Endosc. 2007 May; 65(6):757-66. PMID: 17466195.
    View in: PubMed
  38. Schroy Iii PC, Glick JT, Robinson PA, Heeren T. Screening preferences of patients at familial risk of colorectal cancer. Dig Dis Sci. 2007 Oct; 52(10):2788-95. PMID: 17404844.
    View in: PubMed
  39. Oxentenko AS, Vierkant RA, Pardi DS, Farley DR, Dozois EJ, Hartman TE, Hough DM, Petersen WO, Klabunde CN, Sharpe K, Bond JH, Smith RA, Levin B, Pope JB, Schroy PC, Limburg PJ. Colorectal cancer screening perceptions and practices: results from a national survey of gastroenterology, surgery and radiology trainees. J Cancer Educ. 2007; 22(4):219-26. PMID: 18067433.
    View in: PubMed
  40. Pratap A, Schroy PC. Physical activity and colorectal cancer survival: the more METS the better. Gastroenterology. 2007 Jan; 132(1):456-8. PMID: 17241898.
    View in: PubMed
  41. Oxentenko AS, Goel NK, Pardi DS, Vierkant RA, Petersen WO, Kolars JC, Flinchbaugh RT, Wilson TO, Sharpe K, Bond JH, Smith RA, Levin B, Pope JB, Schroy PC, Limburg PJ. Colorectal cancer screening education, prioritization, and self-perceived preparedness among primary care residents: data from a national survey. J Cancer Educ. 2007; 22(4):208-18. PMID: 18067432.
    View in: PubMed
  42. Itzkowitz SH, Jandorf L, Brand R, Rabeneck L, Schroy PC, Sontag S, Johnson D, Skoletsky J, Durkee K, Markowitz S, Shuber A. Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol. 2007 Jan; 5(1):111-7. PMID: 17161655.
    View in: PubMed
  43. Mishkin DS, Schroy PC. Double-balloon endoscopy: Extending the arm of the gastroenterologist. Gastroenterology. 2006 Sep; 131(3):969-71. PMID: 16952572.
    View in: PubMed
  44. Farraye FA, Schroy PC. Chromoendoscopy: a new vision for colonoscopic surveillance in IBD. Gastroenterology. 2006 Jul; 131(1):323-5; discussion 325-6. PMID: 16831617.
    View in: PubMed
  45. Jacobson BC, Schroy PC. The skinny on obesity and reflux. Gastroenterology. 2006 May; 130(6):1925-6. PMID: 16697760.
    View in: PubMed
  46. Syngal S, Stoffel E, Chung D, Willett C, Schoetz D, Schroy P, Jagadeesh D, Morel K, Ross M. Detection of stool DNA mutations before and after treatment of colorectal neoplasia. Cancer. 2006 Jan 15; 106(2):277-83. PMID: 16342248.
    View in: PubMed
  47. Ahn LB, Schroy PC. Statins and colorectal cancer risk: a new panacea? Gastroenterology. 2006 Jan; 130(1):278-80. PMID: 16401495.
    View in: PubMed
  48. Berger BM, Schroy PC, Rosenberg JL, Lai-Goldman M, Eisenberg M, Brown T, Rochelle RB, Billings PR. Colorectal cancer screening using stool DNA analysis in clinical practice: early clinical experience with respect to patient acceptance and colonoscopic follow-up of abnormal tests. Clin Colorectal Cancer. 2006 Jan; 5(5):338-43. PMID: 16512992.
    View in: PubMed
  49. Oviedo JA, Schroy PC. Does celecoxib use increase the risk of cardiovascular events? Gastroenterology. 2005 Oct; 129(4):1348-50. PMID: 16230088.
    View in: PubMed
  50. Mishkin DS, Schroy PC. Fecal occult blood testing: Forget the finger! Gastroenterology. 2005 Jul; 129(1):384-6. PMID: 16705773.
    View in: PubMed
  51. Lowe R, Schroy PC. Early HVPG measurement and tips for acute variceal hemorrhage: is sooner really better? Gastroenterology. 2005 Apr; 128(4):1136-9; discussion 1139. PMID: 15825100.
    View in: PubMed
  52. Schroy PC, Lal SK, Wilson S, Heeren T, Farraye FA. Deficiencies in knowledge and familial risk communication among colorectal adenoma patients. J Clin Gastroenterol. 2005 Apr; 39(4):298-302. PMID: 15758623.
    View in: PubMed
  53. Schroy PC, Glick JT, Geller AC, Jackson A, Heeren T, Prout M. A novel educational strategy to enhance internal medicine residents' familial colorectal cancer knowledge and risk assessment skills. Am J Gastroenterol. 2005 Mar; 100(3):677-84. PMID: 15743368.
    View in: PubMed
  54. Schroy PC, Heeren TC. Patient perceptions of stool-based DNA testing for colorectal cancer screening. Am J Prev Med. 2005 Feb; 28(2):208-14. PMID: 15710277.
    View in: PubMed
  55. Nunes D, Schroy PC. Another step forward: treating HCV infection in HIV coinfected patients. Gastroenterology. 2005 Feb; 128(2):513-5. PMID: 15685568.
    View in: PubMed
  56. Ferrucci JT, Schroy PC. Virtual colonoscopy: good results and not so good results -- why the difference? Gastroenterology. 2004 Nov; 127(5):1633-5; discussion 1635-6. PMID: 15521030.
    View in: PubMed
  57. Bliss CM, Schroy PC. Endoscopic diagnosis and management of hereditary nonpolyposis colorectal cancer. Curr Opin Gastroenterol. 2004 Sep; 20(5):468-73. PMID: 15689681.
    View in: PubMed
  58. Farraye F, Schroy PC. Tailoring use of screening colonoscopy: are we up to the challenge? Gastroenterology. 2004 Aug; 127(2):673-5. PMID: 15300599.
    View in: PubMed
  59. Chang M, Schroy PC. Endoscopic colorectal cancer screening--can supply meet demand? Gastroenterology. 2004 May; 126(5):1482-5. PMID: 15131811.
    View in: PubMed
  60. Lal SK, Barrison A, Heeren T, Schroy PC. A national survey of flexible sigmoidoscopy training in primary care graduate and postgraduate education programs. Am J Gastroenterol. 2004 May; 99(5):830-6. PMID: 15128345.
    View in: PubMed
  61. Bliss CM, Schroy III PC. Primary Intestinal Lymphangiectasia. Curr Treat Options Gastroenterol. 2004 Feb; 7(1):3-6. PMID: 14723832.
    View in: PubMed
  62. Barrison AF, Smith C, Oviedo J, Heeren T, Schroy PC. Colorectal cancer screening and familial risk: a survey of internal medicine residents' knowledge and practice patterns. Am J Gastroenterol. 2003 Jun; 98(6):1410-6. PMID: 12818289.
    View in: PubMed
  63. Levin B, Smith RA, Feldman GE, Colditz GA, Fletcher RH, Nadel M, Rothenberger DA, Schroy PS, Vernon SW, Wender R. Promoting early detection tests for colorectal carcinoma and adenomatous polyps: a framework for action: the strategic plan of the National Colorectal Cancer Roundtable. Cancer. 2002 Oct 15; 95(8):1618-28. PMID: 12365008.
    View in: PubMed
  64. Schroy PC, Heeren T, Bliss CM, Bliss CM, Pincus J, Wilson S, Prout M. On-site screening sigmoidoscopy promotes long-term utilization but fails as a venue for training primary care endoscopists. Gastroenterology. 2002 May; 122(5):1226-34. PMID: 11984508.
    View in: PubMed
  65. Schroy PC, Barrison AF, Ling BS, Wilson S, Geller AC. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol. 2002 Apr; 97(4):1031-6. PMID: 12008667.
    View in: PubMed
  66. Ling BS, Moskowitz MA, Wachs D, Pearson B, Schroy PC. Attitudes toward colorectal cancer screening tests. J Gen Intern Med. 2001 Dec; 16(12):822-30. PMID: 11903761.
    View in: PubMed
  67. Schroy PC, Geller AC, Crosier Wood M, Page M, Sutherland L, Holm LJ, Heeren T. Utilization of colorectal cancer screening tests: a 1997 survey of Massachusetts internists. Prev Med. 2001 Nov; 33(5):381-91. PMID: 11676578.
    View in: PubMed
  68. Pho K, Geller A, Schroy PC. Lack of communication about familial colorectal cancer risk associated with colorectal adenomas (United States). Cancer Causes Control. 2000 Jul; 11(6):543-6. PMID: 10880036.
    View in: PubMed
  69. Geller AC, Prout MN, Sun T, Krane R, Schroy PC, Demierre MF, Benjes LS, Abd-El-Baki J, Mozden P, Koh HK, Stanfield L. Cancer skills laboratories for medical students: a promising approach for cancer education. J Cancer Educ. 2000; 15(4):196-9. PMID: 11199234.
    View in: PubMed
  70. Fenlon HM, Nunes DP, Schroy PC, Barish MA, Clarke PD, Ferrucci JT. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps. N Engl J Med. 1999 Nov 11; 341(20):1496-503. PMID: 10559450.
    View in: PubMed
  71. Schroy PC, Heeren T, Bliss CM, Pincus J, Wilson S, Prout M. Implementation of on-site screening sigmoidoscopy positively influences utilization by primary care providers. Gastroenterology. 1999 Aug; 117(2):304-11. PMID: 10419910.
    View in: PubMed
  72. Lucas W, Schroy PC. Reversible ischemic colitis in a high endurance athlete. Am J Gastroenterol. 1998 Nov; 93(11):2231-4. PMID: 9820403.
    View in: PubMed
  73. Schroy PC. Per-procedure endoscopy costs. Gastrointest Endosc. 1997 Jul; 46(1):90-1. PMID: 9260718.
    View in: PubMed
  74. Schroy PC, Wilson S, Afdhal N. Feasibility of high-volume screening sigmoidoscopy using a flexible fiberoptic endoscope and a disposable sheath system. Am J Gastroenterol. 1996 Jul; 91(7):1331-7. PMID: 8677989.
    View in: PubMed
  75. Singh P, Dai B, Yallampalli U, Lu X, Schroy PC. Proliferation and differentiation of a human colon cancer cell line (CaCo2) is associated with significant changes in the expression and secretion of insulin-like growth factor (IGF) IGF-II and IGF binding protein-4: role of IGF-II. Endocrinology. 1996 May; 137(5):1764-74. PMID: 8612513.
    View in: PubMed
  76. Schroy PC, Brown-Shimer S, Kim K, Johnson KA, Murnane MJ, Yang S, O'Brien MJ, Carney WP, Kupchik HZ. Detection of p21ras mutations in colorectal adenomas and carcinomas by enzyme-linked immunosorbent assay. Cancer. 1995 Jul 15; 76(2):201-9. PMID: 8625092.
    View in: PubMed
  77. Salomons HA, Kramer P, Nikulasson S, Schroy PC. Endoscopic features of long-standing primary intestinal lymphangiectasia. Gastrointest Endosc. 1995 May; 41(5):516-8. PMID: 7615236.
    View in: PubMed
  78. Schroy PC, Rustgi AK, Ikonomu E, Liu XP, Polito J, Andry C, O'Keane JC. Growth and intestinal differentiation are independently regulated in HT29 colon cancer cells. J Cell Physiol. 1994 Oct; 161(1):111-23. PMID: 7929596.
    View in: PubMed
  79. Kelly CP, O'Keane JC, Orellana J, Schroy PC, Yang S, LaMont JT, Brady HR. Human colon cancer cells express ICAM-1 in vivo and support LFA-1-dependent lymphocyte adhesion in vitro. Am J Physiol. 1992 Dec; 263(6 Pt 1):G864-70. PMID: 1362041.
    View in: PubMed
  80. McQuillen DP, Schroy PC, Hesketh PJ, Sugar AM. Pneumocystis carinii pneumonia complicating somatostatin therapy of Cushing's syndrome in a patient with metastatic pancreatic islet cell carcinoma and Zollinger-Ellison syndrome. Am J Gastroenterol. 1991 Apr; 86(4):512-4. PMID: 1672788.
    View in: PubMed
  81. Schroy PC, Cohen A, Winawer SJ, Friedman EA. Effects of FUdR on primary-cultured colon carcinomas metastatic to the liver. J Surg Oncol. 1990 Dec; 45(4):217-23. PMID: 2147452.
    View in: PubMed
  82. O'Keane JC, Kupchik HZ, Schroy PC, Andry CD, Collins E, O'Brien MJ. A three-dimensional system for long-term culture of human colorectal adenomas. Am J Pathol. 1990 Dec; 137(6):1539-47. PMID: 2260636.
    View in: PubMed
  83. Schroy P, Rifkin J, Coffey RJ, Winawer S, Friedman E. Role of transforming growth factor beta 1 in induction of colon carcinoma differentiation by hexamethylene bisacetamide. Cancer Res. 1990 Jan 15; 50(2):261-5. PMID: 2295065.
    View in: PubMed
  84. Schroy P, Winawer S, Friedman E. Effect on in vivo tumorigenicity of lengthy exposure of human colon cancer cells to the differentiation agent hexamethylene bisacetamide. Cancer Lett. 1989 Nov 15; 48(1):53-8. PMID: 2819696.
    View in: PubMed
  85. Schroy PC, Carnright K, Winawer SJ, Friedman EA. Heterogeneous responses of human colon carcinomas to hexamethylene bisacetamide. Cancer Res. 1988 Oct 1; 48(19):5487-94. PMID: 2458179.
    View in: PubMed
  86. Schroy PC, Wiggins T, Winawer SJ, Diaz B, Lightdale CJ. Video endoscopy by nurse practitioners: a model for colorectal cancer screening. Gastrointest Endosc. 1988 Sep-Oct; 34(5):390-4. PMID: 3181698.
    View in: PubMed
  87. Schroy PC, Cohen A, Winawer SJ, Friedman EA. New chemotherapeutic drug sensitivity assay for colon carcinomas in monolayer culture. Cancer Res. 1988 Jun 1; 48(11):3236-44. PMID: 2966672.
    View in: PubMed
  88. Shike M, Schroy P, Ritchie MA, Lightdale CJ, Morse R. Percutaneous endoscopic jejunostomy in cancer patients with previous gastric resection. Gastrointest Endosc. 1987 Oct; 33(5):372-4. PMID: 3678765.
    View in: PubMed
  89. Flombaum CD, Schroy P, Watson R, Vanamee P. Treatment of acute obstructive renal failure with high-dose methylprednisolone. Arch Intern Med. 1986 Jan; 146(1):58-61. PMID: 3510599.
    View in: PubMed
Paul's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
BU Co-Authors
_
Similar BU People
_
Same Department